# FDA Inspection 1152923 - Paramesh Banerji Life Sciences, LLC - September 24, 2021

Source: https://www.keypedia.com/records/fda_inspections/paramesh-banerji-life-sciences-llc/5ce1908f-a2a3-421e-9c72-306f03e67cab
Source feed: FDA_Inspections

> FDA Inspection 1152923 for Paramesh Banerji Life Sciences, LLC on September 24, 2021. Classification: Official Action Indicated (OAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1152923
- Company Name: Paramesh Banerji Life Sciences, LLC
- Inspection Date: 2021-09-24
- Classification: Official Action Indicated (OAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1216826 - 2023-08-24](https://www.keypedia.com/records/fda_inspections/paramesh-banerji-life-sciences-llc/9ca496cf-2611-4c47-b3f5-65267c4bb61d)
- [FDA Inspection 1034097 - 2017-12-07](https://www.keypedia.com/records/fda_inspections/paramesh-banerji-life-sciences-llc/134d2410-7ec4-4a4b-a46f-f1fcd74cd2ec)

Company: https://www.keypedia.com/companies/paramesh-banerji-life-sciences-llc/8a5dcf24-e253-4116-a968-f9b1a890d15b

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c